SPHRF
STARPHARMA HOLDINGS LTD by Starpharma Holdings Ltd. (SPHRF)
$
07About STARPHARMA HOLDINGS LTD by Starpharma Holdings Ltd. (SPHRF)
Starpharma Holdings Ltd. engages in the research and development of dendrimer products for pharmaceutical, life science and other applications. Its programs include: VivaGel portfolio, Drug delivery and Agrochemicals, which develops a number of products internally and others via commercial partnerships. Its product is VivaGel, a gel-based formulation of a proprietary dendrimer and is under clinical development for the treatment and prevention of bacterial vaginosis and also as a vaginal microbicide to prevent the transmission of sexually transmitted infections including HIV and genital herpes. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.10
52 Week Low
$0.05
Market cap
29.6M
Dividend yield
0.00%
Volume
--
Avg. volume
485
P/E ratio
--
STARPHARMA HOLDINGS LTD by Starpharma Holdings Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.10
52 Week Low
$0.05
Market cap
29.6M
Dividend yield
0.00%
Volume
--
Avg. volume
485
P/E ratio
--